News

Researchers at Mount Sinai’s Tisch Cancer Institute have identified a new gene that is essential to colon cancer growth and found that inflammation in the external environment around the tumor can contribute to the growth of tumor cells.

According to research, a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug can suppress the growth of triple-negative breast cancer cells synergistically.

Cancer-induced muscle wasting is a common complication in the late stages of cancer. New research has identified a key enzyme that drives the condition, opening doors to developing treatments.

Women who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report using these products, according to a new study.

Researchers have investigated how breast cancer cells become resistant to endocrine therapy, revealing a mechanism that both explains the process and offers possibilities to overcome it.

An analysis of patients with invasive lobular carcinoma, the second most common subtype of breast cancer in the US, showed that it is detected later and has worse outcomes than the predominant subtype of breast cancer, invasive ductal carcinoma.

According to research, a new therapy currently undergoing clinical trials promotes a potent immune response by binding to fibroblasts, enabling it to overcome resistance to anti-HER2 therapy in tumors.

Scientists have shown that sex-based differences in adrenal cancer prognosis could be due to differences in testosterone levels, which is involved in recruiting tumor-fighting macrophages.

A platform has been developed that connects cancer patients to appropriate clinical trials, based on genetic alterations in their tumors.

According to research, observing the two patterns of invasion used in ovarian cancer could help oncologists better predict patient prognoses and select treatments accordingly.